Barely Significant
← all excerpts

Permanent seed brachytherapy for prostate cancer: Monotherapy, combined, and salvage approaches remain effective and well-tolerated options.

J Contemp Brachytherapy · 2026 · PMC13225094 · PMID 42232845

1
hedged sentence
closest p
boldest claim

The sentences

In our series, patients treated with brachytherapy boost achieved numerically higher biochemical relapse-free survival compared with monotherapy, although this difference did not reach statistical significance, likely reflecting treatment heterogeneity and limited event numbers.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.